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ABSTRACT Increasing evidence suggests an important role for VPAC2-activated signal transduction pathways in maintaining
a synchronized biological clock in the suprachiasmatic nucleus (SCN). Activation of the VPAC2 signaling pathway induces per1
gene expression in the SCN and phase-shifts the circadian clock. Mice without the VPAC2 receptor lack an overt, coherent
circadian rhythm in clock gene expression, SCN neuron ﬁring rate, and locomotor behavior. Using a systems approach, we
have developed a kinetic model integrating VPAC2 signaling mediated by the cyclic AMP (cAMP)/protein kinase A (PKA)
pathway and leading to induced circadian clock gene expression. We ﬁt the model to experimental data from the literature for
cAMP accumulation, PKA activation, cAMP-response element binding protein phosphorylation, and per1 induction. By linking
the VPAC2 model to a published circadian clock model, we also simulated clock phase shifts induced by vasoactive intestinal
polypeptide (VIP) and matched experimental data for the VIP response. The simulated phase response curve resembled the
hamster response to a related neuropeptide, GRP1–27, and light. Simulations using pulses of VIP revealed that the system
response is extraordinarily robust to input signal duration, a result with physiologically relevant consequences. Lastly, sim-
ulations using varied receptor levels matched literature experimental data from animals overexpressing VPAC2 receptors.
INTRODUCTION
The suprachiasmatic nucleus (SCN) is the site of the master
biological clock in mammals, where many of the circadian
oscillations throughout the body, including overt locomotor
behavioral rhythmicity, are orchestrated (1). Synchronization
of the SCN with daily light/dark cycles, food availability,
and temperature variations, etc., is maintained by numerous
environmental inputs. In addition, the SCN receives phys-
iological feedback from peripheral tissues for ﬁne-tuning the
phase relationships between the various rhythms in the body.
Furthermore, within the SCN itself, cells communicate with
one another to maintain synchrony. Synchronization and
entrainment in the SCN is in part accomplished through
intracellular signal transduction pathways.
There is abundant evidence indicating that many neuro-
peptides modulate the SCN circadian clock oscillation (2,3).
Vasoactive intestinal polypeptide (VIP), a versatile neuro-
peptide, plays important roles in the circadian clock system.
Microinjection of VIP into the SCN region of Syrian
hamsters during the early or late subjective night produces
phase-shifts similar to those induced by light (3,4). VIP also
induces mammalian per1 gene expression in SCN neurons
(5,6) and phase-shifts the rat SCN clock in vitro (7,8). Two
types of VIP receptors are present in the SCN: VPAC2 and
PAC1 (9). Detailed reporter localization and immunohisto-
chemical studies have demonstrated a high density of
VPAC2 expression in SCN neurons and SCN VIP efferent
target neurons (10,11). The VPAC2 receptor afﬁnity for VIP
is three orders of magnitude higher than that of PAC1 (12). In
addition, alterations in VPAC2 expression profoundly disrupt
the circadian system. For example, mice overexpressing
VPAC2 exhibit a shorter free-running period (13), whereas
mice deﬁcient in this receptor lack circadian rhythms in both
locomotor behavior and clock gene expression (14). Loss of
VIP also disrupts locomotor behavior rhythms, abolishes
circadian ﬁring rhythms in approximately half of all SCN
neurons, and disrupts synchrony between rhythmic neurons
(15). These observations suggest that VPAC2 may contribute
to autoregulation and/or synchronization within the SCN.
Although the signaling pathways mediating the actions of
VIP are becoming established in other systems, they are less
clearly delineated in the SCN circadian clock cells. VPAC2 is a
G-protein-coupled receptor that has been clearly linked to
the stimulating guanine nucleotide binding protein (Gs) and
adenylyl cyclase (AC), with cyclic AMP (cAMP) implicated
as a key second messenger in many tissues (12,16). In adeno-
carcinoma cells, VIP binding to VPAC2 has been shown to
activate the cAMP/protein kinase A (PKA) signal transduction
pathway (17), whereas in pinealocytes, VPAC2 activation leads
to phosphorylation and activation of the transcription factor
cAMP-response element binding protein (CREB), a PKA
target (18). In pituitary tumor cells, activation of the phospho-
lipase C/inositol-phosphate pathway downstream of VPAC2
also leads to CREB activation through mitogen-activated pro-
tein kinase pathways (19). Activated CREB in turn induces
gene expression, for example, in human choriocarcinoma
cells CREB induces per1 gene expression through CRE elements
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present in the per1 gene promoter (20). In SCN slices and
dissociated SCN cells, VIP induces cAMP synthesis (21, 22). In
ex vivo experiments, both PKA and mitogen-activated protein
kinase have been shown to play roles in VIP-induced phase shifts
in the spontaneous ﬁring rhythms of SCN neurons (7). These
results suggest that signaling downstream of VPAC2 in the
SCN is similar to VPAC2 signaling in other systems.
Many signaling pathways in the SCN are gated by the
circadian clock such that the functional consequences of sig-
naling depend on the phase of the clock when the signaling is
initiated (2). The functional consequences of VIP signaling
through cAMP/PKA is also gated by the circadian clock in
such a way that VIP, like light, only induces phase shifts and
per1 expression during the circadian night (3,4,5,6,23). Where
along the signaling pathway the gating occurs is not clear.
To understand the dynamics of VPAC2 receptor signaling,
how it modulates circadian clock function, and how it is gated
by the circadian clock, we have undertaken a computational
modeling study of this system in this work. Speciﬁcally, we
have focused on how the topology and interacting compo-
nents of the VPAC2 signaling pathway contribute to the
control of clock gene induction and how the circadian clock
responsiveness to VIP stimulation is gated. We ﬁt the model
to a wide range of experimental data from the literature for
cAMP accumulation, PKA activation, and CREB phospho-
rylation. We linked the VPAC2 model to a mammalian cir-
cadian clock model (24,25) and observed phase shifts similar
to what has been observed in vivo and in vitro. Interestingly,
our simulations reveal that the system response to short
pulses of VIP is nearly equivalent to the response to step
changes in VIP concentration, a result with physiologically
relevant consequences. Results of simulation studies with
varied receptor levels agree with published experimental
results for mice overexpressing the VPAC2 receptor, pro-
viding additional validation of the model. Together, the mod-
eling and simulation results of this study provide a framework
for gaining increased understanding of the modulation of
circadian clock properties by extracellular inputs.
MATERIALS AND METHODS
The VPAC2 model of this work is an extension of the cAMP/PKA signal-
ing pathway framework described by Bhalla (26). Key reaction modules are
shown in Fig. 1, A–H, describing the VIP-activated cAMP/PKA signal trans-
duction that ultimately leads to gene induction in the nucleus. The model in-
corporates the following molecular processes originally modeled by Bhalla (26):
1. Ligand (L) binding to receptor (R) (Fig. 1 A). The receptors exist either
by themselves or coupled with G-protein (R.GDP.Gs).
2. G-protein activation (Fig. 1 B). When ligand binds to the receptor
coupled with G-protein (L.R.GDP.Gs), it induces guanine triphosphate
(GTP)/guanine diphosphate (GDP) exchange and G-protein activation
(GTP.Ga).
3. Adenylate cyclase (AC) activation (Fig. 1 C). Activated Ga binds AC,
forms activated adenylate cyclase (Gas.AC), and produces cAMP.
4. PKA activation (Fig. 1 D). Four cAMP molecules bind sequentially to
each PKA inactive heterotetramer (R2C2) and release two activated
PKA catalytic subunits.
5. Phosphodiesterase activation (Fig. 1 E). Activated PKA activates cAMP
phosphodiesterase (PDE), which converts cAMP to AMP.
6. PKA inhibition (Fig. 1 H). A cytoplasmic protein slowly inhibits PKA
activity.
We extended the above framework to describe VPAC2 signaling by
including the following processes:
1. Receptor internalization (Fig. 1,A and B). The receptor-ligand complex
is internalized as described by Langlet et al. (27), providing another
mechanism for the attenuation of signaling.
2. Basal cAMP formation. To maintain a nonzero steady-state level of
cellular cAMP, a nonspeciﬁc low level of G-protein activity was added,
maintaining cAMP at ;0.15 nM (21,28).
3. Additional PKA dynamics (Fig. 1 H). PKA nuclear translocation was
added to bridge cytoplasmic signaling with the nucleus. PKA nuclear
inhibition and translocation back to the cytoplasm was added to ter-
minate PKA nuclear action. PKA heterodimerization with regulatory
units was added to replenish the inactive PKA pool.
4. CREB activation (Fig. 1 F). CREB phosphorylation by nuclear PKA
was modeled, extending the intracellular signaling to gene regulation.
5. Clock gene (per1) induction (Fig. 1 G). Per1 promoter binding by
phosphorylated CREB and subsequent transcriptional activation was
modeled, bridging the VPAC2 signaling pathway model to the core
circadian clock. Transcriptional regulation of per1 by CREB was
modeled using the framework employed by Leloup and Goldbeter
(24,25) to model circadian regulation of per1:
dMp
dt
¼ nsp ðCREB
  CREB0Þn
K
n
CP1 ðCREB  CREB0Þn
 nmp Mp
Kmp1Mp
 kdmpMp; (1)
where Mp is the per1 mRNA level, CREB* is the phosphorylated CREB
level, CREB*0 is the level of phosphorylated CREB in the absence of VIP,
vsp is the maximum per1 transcription rate, KCP is the phosphorylated CREB
level for half-maximal transcription, n is the degree of cooperativity of
activation of per1 transcription by CREB, vmp is the maximal saturating
enzymatic degradation of per1mRNA, Kmp is the per1mRNA level for half-
maximal degradation, and kdmp is the nonsaturating per1mRNA degradation
constant.
The overall VPAC2 signaling network is shown in ﬂow diagram format in
Fig. 1 I, where the complex feedback loops and intrinsically self-limiting
nature of the pathway are apparent. Overall, the VPAC2 signaling path-
way model consists of 36 ordinary differential equations (ODEs) and 66
parameters. It is a single-cell model where the cytoplasm and nucleus are
assumed to be ‘‘well-stirred (but separate) compartments’’, i.e., perfect
diffusional access to all components within each compartment. All reaction
rates were based on standard mass action kinetics, except for the Hill
function and Michaelis-Menten terms in Eq. 1.
The model parameters were tuned as follows:
1. The initial values for the ﬁrst 40 parameters were obtained from Bhalla
(26); the remaining parameters were assigned coarse initial estimates.
2. Experimental data from the literature were collected for the VIP
responses of several system components, including cAMP, PKA, and
CREB phosphorylation.
3. We ﬁt the experimental data for each system component individually,
starting with cAMP (early in the signaling pathway), and ﬁnish with
CREB phosphorylation (bridging the signaling pathway to the nucleus).
4. For each system component model, we performed a sensitivity analysis in
which all of the model parameters were tested for how strongly they
affected the system response. Values of the parameters that most strongly
controlled the concentration proﬁle of the system component were varied
until the simulation predictions matched the experimental data closely.
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Parameters that remain unchanged from the original values reported
in Bhalla (26) were related to ligand binding, receptor/G-protein coupling,
G-protein activation, AC activation, and PKA inhibition (speciﬁcally, k1, k2,
k5, k6, k7, k9, k10, k11, k16, k18, and k29—see Supplementary Material). A
complete list of all equations, parameters, and initial values is provided in the
Supplementary Material.
As described above, sensitivity analysis played an important role in our
parameter ﬁtting procedure. We also employed sensitivity analysis to gain
insight into the model behavior itself. We used the accumulated per1mRNA
concentration over the increasing phase of the induction as a system output
and evaluated the extent to which it was affected by variations in the model
parameters. More speciﬁcally, the following formula was used to calculate a
scaled change in per1 output in response to a change in parameter value (S):
S ¼
+
i
ðyðtiÞ  ybaseðtiÞÞ
+
i
ybaseðtiÞ
p pbase
p
 1
; (2)
where y(ti) is the level of per1 at time ti for the perturbed parameter value,
ybase(ti) is the level of per1 in the unperturbed case, pbase is the initial parameter
value, and p is the perturbed parameter value. The simulations were performed
until t ¼ 2000 s (VIP treatment at t ¼ 0) and S value were calculated using 50
time points from t ¼ 1000 s to t ¼ 2000 s with a sampling time of 20 s.
Parameters were varied individually, over a range from 0.5 to 2 times the
nominal values. This local sensitivity analysis (29) provided insights into the
biological processes most important in controlling the system output.
FIGURE 1 (A-H) Schematic kinetic
reactions of VIP-activated signaling
process leading from receptor binding
to activated gene transcription. Revers-
ible reactions are represented by dou-
ble arrows and enzymatic reactions are
represented by enzyme species over
the single arrow reactions. Ligand re-
ceptor complex internalization is repre-
sented by dotted line arrows. L, ligand
(VIP); R, receptor; L.R, ligand recep-
tor complex; R.GDP.Gs, receptor
G-protein complex; L.R.GDP.Gs, lig-
and bound receptor G-protein complex;
GTP.Ga, activated G-protein; Gbg,
G-proteinb- and g-subunit; AC, adenylyl
cyclase; Ga.AC, stimulatory G-protein-
activated AC; GDP.Gs, GDP-bound
G-protein trimer; R2C2, protein kinase
A catalytic unit/regulatory unit hetero-
tetramer; cAMP.R2C2-cAMP4.R2C2,
cAMP complexed with PKA tetramer;
PDE, phosphodiesterase; PDE*, phos-
phorylated phosphodiesterase; CREB*,
phosphorylated CREB. (I) Flow sheet
of the overall VPAC2 signaling reaction
network. Abbreviations are as above,
except that PR2 indicates PKA regula-
tory subunit dimer and IPKA indicates
PKA inhibitor. (J) Flow sheet for the
Leloup and Goldbeter (24,25) mamma-
lian circadian rhythm model with input
from the VPAC2 model, adapted from
Leloup and Goldbeter (24). Degrada-
tions are indicated by dotted arrows.
1562 Hao et al.
Biophysical Journal 90(5) 1560–1571
We also investigated the sensitivity of the model responses to the duration
of the VIP input signal. As for the local sensitivity analysis described above,
we used per1 mRNA concentration time course proﬁle as the output, but
instead of computing sensitivity coefﬁcients, we simply compared the time
courses for differing pulse durations. We considered VIP inputs at 100 nM
concentration with pulse durations ranging from 1 to 30 min.
To simulate the circadian phase-shifting properties of VIP in the SCN, we
linked the VPAC2 signaling pathway model to the short form of Leloup and
Goldbeter (24,25) mammalian circadian clock model. The Leloup and
Goldbeter (24,25) model describes the transcriptional feedback network
consisting of the core clock proteins Per1, Cry, and Bmal1/Clock and their
posttranslational regulation by reversible phosphorylation. It consists of 16
ODEs with 53 parameters and is shown schematically in Fig. 1 J. We linked
the Leloup and Goldbeter (24,25) model to our VPAC2 signaling model
through transcriptional regulation of per1, a gene induced downstream of
VPAC2 that is also a core clock gene. Regulation of per1 transcription by
VPAC2 signaling and the circadian clock is accomplished by two different
mechanisms. In the ﬁrst case, per1 induction is mediated by CREB (as
described in the model above), whereas in the second it is mediated by
nuclear Bmal1/Clk protein complexes. It has been shown that the two
mechanisms are independent (to a degree) in that disruption of CREB
binding sites has no impact on per1 regulation by Bmal1/Clk (20). This
independence has led us to postulate two functional hypotheses about the
mechanisms by which the circadian clock and VPAC2 signaling jointly
regulate per1 induction, shown here in Eqs. 3 and 4:
dMp
dt
¼ nsp B
n
N1 ðCREB  CREB0Þn
K
n
BCP1B
n
N1 ðCREB  CREB0Þn
 nmp Mp
Kmp1Mp
 kdmpMp (3)
dMp
dt
¼ nsp B
n
N
K
n
BCP1B
n
N
1 nsp
ðCREB  CREB0Þn
K
n
CP1 ðCREB  CREB0Þn
 nmp Mp
Kmp1Mp
 kdmpMp; (4)
where the symbols are as deﬁned for Eq. 1 with the addition of BN
representing the level of nuclear Bmal1/Clk complex. Equation 3 is a model
for the case where CREB and Bmal1/Clk function independently but recruit
the transcriptional apparatus by the same means. In this case, if the levels of
Bmal1/Clk are high enough for transcriptional recruitment to be saturated,
activation of CREB will not lead to further increase in transcriptional
initiation (Fig. 2 A). The functional form is based on that employed by Ueda
et al. (30). Equation 4 is a model for the case where CREB and Bmal1/Clk
recruit the transcriptional apparatus through separate mechanisms, and thus
activation of CREB may lead to either additive or synergistic transcriptional
activation of per1 in connection with Bmal/Clk (Fig. 2 B).
The models were implemented in MATLAB (The MathWorks, Natick,
MA) and simulations were performed using the MATLAB stiff ODE
integrator ode15s (31).
RESULTS
Model development and validation
We expanded the framework developed by Bhalla (26) for
the cAMP/PKA signaling pathway and used it to describe the
VIP receptor VPAC2-activated signaling through the cAMP/
PKA pathway to circadian clock gene per1 induction in the
circadian pacemaker SCN cells. This model has incorporated
PKA nuclear translocation upon activation, CREB phospho-
rylation by PKA, and the ensuing gene activation. To capture
the dynamics of VPAC2 signaling with our model, we
systematically tuned the model parameters to match exper-
imental data from the literature. Speciﬁcally, we systemat-
ically varied the parameters until we converged on a set of
values for which the model predictions optimally matched
the experimental kinetic proﬁles for cAMP accumulation,
PKA activation, and CREB phosphorylation simultaneously.
The details for each model component are given below.
Fitting VIP-induced cAMP accumulation
As described above, VPAC2 is a GPCR coupled with Gs
that activates the cAMP/PKA signaling pathways. To ﬁt the
model to literature data on VIP-induced cAMP accumula-
tion, we performed a local sensitivity analysis to identify
the most sensitive parameters for cAMP production, as de-
scribed in the Materials and Methods section. The param-
eters most important for matching the cAMP proﬁle were
related to G-protein coupling to ligand-receptor complex
(k3 and k4), ligand binding to receptor-G-protein complex
(k7 and k8), G-protein activation (k10), cAMP production
(k12, k13, and k14), cAMP hydrolysis (k35, k36, and k37), and
GTP hydrolysis (k43) (data not shown). These parameters were
then varied individually to ﬁt experimental data. After ﬁtting
the model, we obtained kinetic proﬁles in cAMP accumu-
lation in response to VIP treatment similar to those obtained
FIGURE 2 Schematic representation of the two mechanisms for the
combined VIP signaling- and circadian clock-regulated per1 gene expres-
sion. (A) The mechanism represented by Eq. 3, where either VIP signaling-
activated CREB or the circadian transcription factor Bmal1/Clk can activate
the transcription machinery to reach its maximum rate. When both are
present, it is effectively as if only one is binding to the transcriptional
machinery at a time to reach the maximum rate of transcription. (B) The
mechanism represented by Eq. 4, where both CREB and Bmal1/Clk can
activate the gene transcription to their individual respective maxima. When
both are present, they both bind to the transcriptional machinery and have an
additive or synergistic effect on the rate of transcription. C, CREB; B/C,
Bmal1/Clk; Pol II, RNA polymerase II. The arrow denotes the direction of
per1 transcription.
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with cultured GH3 cells (28), as shown in Fig. 3. The sim-
ulated cAMP accumulation shows a fast increasing phase,
a peak in ;5–10 min after VIP treatment, and then a slow
decrease back to basal level (Fig. 3 A). A comparison of our
simulation results to the cAMP increase in GH3 cells, ex-
perimentally measured at a single time point, is shown in
Fig. 3 A. The simulated cAMP accumulation also showed dose
dependence with an EC50 ¼ 1.5 nM compared to EC50 ¼
2.2 nM as reported in GH3 cells (28) (Fig. 3 B). It is also
interesting to note that the experimentally obtained dose
response curve showed a decrease in cAMP level at 100 nM
VIP concentration as compared to at 10 nM. However, our
simulated cAMP kinetic proﬁle showed a corresponding
increase in cAMP peak level with increasing VIP concen-
tration (Fig. 3 A). The discrepancies arise from the timing of
the sampling: the experimental data were obtained 15 min
after VIP treatment, which our simulations indicate (at least
for higher VIP concentrations) was already beyond the time
for the peak level of cAMP (Fig. 3 A). Because our sim-
ulation indicated a slightly different kinetic proﬁle for
different concentrations, and because of the discrepancies
between our simulation and reported dose response curve, it
would be desirable to measure cAMP increases across a time
span and at different VIP concentrations to cover the whole
dynamic range of cAMP concentration.
Fitting VIP-induced PKA activation
One effect of elevated cAMP concentration in the cytosol is
activation of PKA. In our simulation, PKA activation follows
cAMP accumulation with a slight delay, with increasing
cAMP accumulation resulting in increased PKA activation.
The procedure for ﬁtting the model to reported PKA activation
proﬁle is similar to the procedure described above for cAMP
(see previous section). We matched our model predictions to
experimental observations in cultured cells (17), where PKA
activation peaked ;5 min after VIP treatment and returned
to baseline within 20 min (Fig. 4). The most important
parameters for ﬁtting the PKA activation proﬁle are related to
active PKA nuclear translocation (k45), nuclear active PKA
inhibition (k49 and k50), PKA inhibitor nuclear translocation
(k57 and k58), and cAMP hydrolysis from PKA regulatory
units (k60). The association constant (Ka) value we obtained
from the model ﬁtting, 0.5 nM, is very close to the
experimentally determined value of 0.4 nM (17). However,
without quantitative kinetic data, the ﬁtting had to be
qualitative, and the simulated results are in arbitrary units.
Nonetheless, the simulated PKA activation resembles exper-
imentally observed PKA activation proﬁles quite well (17).
FIGURE 3 VIP-induced cAMP accumulation. (A) Simulated cAMP
accumulation at different VIP concentrations. VIP addition was at t ¼ 0.
Symbols represent experimentally observed cAMP concentration at 800 s in
GH3 cells (see Mackenzie et al. (28)). Different symbols correspond to
different VIP concentrations as denoted in the legend. (B) Simulated dose
response curve (solid line) compared to experimental data (s) that obtained
from GH3 cells (28), 15 min after VIP treatment.
FIGURE 4 Simulated PKA, phosphorylated CREB, and per1 mRNA
concentrations after VIP administration at time 0. All concentrations are
normalized to give respective peak levels of 1. Dotted line is simulated PKA
concentrations, dashed line is simulated phosphorylated CREB concentra-
tion, and solid line is simulated per1mRNA concentration. (¤) Per1mRNA
expression data following foskolin stimulation from Yagita and Okamura
(32).
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Fitting VIP-induced CREB phosphorylation
Activation of the cAMP/PKA signaling pathway leads to
transcriptional activation via activation of the CREB. Using
a procedure similar to the ones in the two previous sections,
we matched our model predictions to data from one detailed
study in the rat pinealocyte that considered phosphorylation
of CREB after VIP treatment (18). In both the experimental
study and our simulations, phospho-CREB reaches peak
levels 30 min after VIP treatment and returns to baseline in
;2 h (Fig. 4). The most important parameters controlling the
CREB phosphorylation proﬁle were related to CREB phos-
phorylation (k47 and k48) and dephosphorylation (k59). Similar
to PKA activation, only qualitative ﬁtting was possible and
the simulated CREB activation proﬁle is in arbitrary units.
VIP-induced per1 gene expression
VIP induces the clock genes per1 and per2 in the SCN at least
partly through the cAMP/PKA signaling pathways (6). We
included CREB-mediated gene activation in our model using
the scheme employed by Leloup and Goldbeter (24,25) (Eq. 1)
and including per1 induction after VIP treatment. Using the
parameters for per1 mRNA accumulation from the Leloup
and Goldbeter model, our simulations results show per1
transcripts peaking ;100 min after VIP treatment, returning
to basal level in ;240 min (Fig. 4). These results resemble
forskolin-induced per1 expression in rat-1 ﬁbroblasts (32),
an in vitro model of the mammalian circadian clock (33).
Model sensitivity analysis
To assess the sensitivity of per1 induction to parameter
changes, we systematically varied each individual parameter
by a factor of 0.5, 0.95, 1.05, or 2, and computed scaled
percentage changes in per1 mRNA concentrations during
the increasing phase of induction as described in the Materials
and Methods section (Eq. 2). Of the 66 parameters, 16 gave
changes .625% under at least one of the changed con-
ditions; 16 parameters gave changes ,25% but .5% under
at least one of the changed conditions; and 34 parameters
either did not change the per1 expression under any of
the changed conditions or the changes were ,5%. The most
sensitive parameters include, in order of importance, vsp
(maximum rate for per1 mRNA synthesis), k49 (binding rate
for nuclear inhibitor binding to nuclear PKA), k59 (CREB*
dephosphorylation rate), k12 (rate of cAMP production by
activated AC), k13 (rate of ATP binding to activated AC), k51
(rate for nuclear-inhibited PKA translocation to cytoplasm),
k55 (rate of inhibited PKA to reform holoenzyme with PKA
regulatory unit), k46 (rate for PKA binding to CREB), k50
(dissociation rate for nuclear inhibitor bound to PKA), k57
(rate of PKA inhibitor nuclear translocation), k10 (rate of
G-protein activation), k52 (rate of backward translocation of
inhibited PKA to nuclei), vmp (maximum rate for per1mRNA
degradation), kmp (Michaelis constant for per1 mRNA
degradation), k14 (dissociation rate for ATP-bound AC), and
k43 (rate of GTP hydrolysis) (Fig. 5 A). The model showed
considerable sensitivity to both increases and decreases in
vsp, vmp, kmp, k12, k13, k14, and k43, but was more sensitive to
increases in k46 and k50 and to decreases in k49, k51, k55, and
k59. Because vsp, vmp, and kmp are directly involved in the
per1 mRNA synthesis and degradation, it is not surprising
that the per1mRNA time course was directly proportional to
changes in these parameters. Similarly, k10, k12, k13, k14, and
k43 are involved in AC activation and cAMP synthesis, and,
not surprisingly, per1 mRNA accumulation was found to be
very sensitive to changes in their values.
The parameters with moderate sensitivity include, in order
of importance, k56 (rate of backward reaction for inactive
PKA holoenzyme re-formation), k58 (rate of backward reac-
tion for PKA inhibitor nuclear translocation), n (degree of
transcription factor cooperativity), k35/36/37 (phosphodiesterase-
catalyzed cAMP degradation), kAP (activation constant
for per1 transcription), k3/4 (liganded receptor binding to
G-protein), k41 (rate of basal G-protein activation), k19/20/21/
22/23 (rate for cAMP binding to PKA holoenzyme), and k42
(rate of receptor internalization) (data not shown).
Per1 induction was not sensitive to the remaining
parameters, including k1/2 (ligand binding to G-protein free
receptors), k5/6 (receptor and G-protein coupling), k7/8
(ligand binding to G-protein-coupled receptors), k9 (trimeric
G-protein formation), k11 (GTP hydrolysis), k15/16 (Ga and
AC binding), k17/18 (rate for ﬁrst cAMP molecule binding to
PKA holoenzyme), k24–28 (rate for releasing PKA catalytic
units), k29/30 (cytoplasmic PKA inhibition), k31–34 (phos-
phodiesterase phosphorylation and dephosphorylation), k38/
39 (phosphorylated phosphodiesterase binding to cAMP),
k44/45 (PKA nuclear translocation), k47 (PKA CREB disso-
ciation), k48 (CREB phosphorylation), k53/54 (PKA tetramer
re-formation), k60 (hydrolysis of cAMP bound to PKA
regulatory units), and kdmp (basal per1 mRNA degradation)
(data not shown).
Overall the sensitivity of the per1 mRNA time course
was similar to what we observed earlier while tuning the
parameters to ﬁt experimental data to the predicted model
responses of speciﬁc key signaling molecules, i.e., cAMP,
PKA, CREB phosphorylation, and per1 induction. However,
it was surprising to note that the overall model was not
sensitive to the rate of PKA dissociation from CREB (k47)
and the rate of CREB phosphorylation (k48). Phosphorylated
CREB concentration is directly linked to per1 transcriptional
activation. The fact that per1 transcriptional induction was
not sensitive to CREB phosphorylation but sensitive to
CREB dephosphorylation suggests that the balance of phos-
phorylated CREB is more dependent upon the rate of dephos-
phorylation.
To this point, all simulations have been performed with a
step input in the VIP signal (i.e., VIP was added and the
concentration held constant in the system throughout the
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simulation run). However, the bioactive effect of VIP in vivo
only lasts a few minutes in biological ﬂuids due to its rapid
degradation and inactivation by enzymes, catalytic anti-
bodies, and spontaneous hydrolysis (see Sethi et al. (34) for a
review). To investigate the effects of transient VIP stimu-
lation, we considered pulses in VIP concentration of 100 nM
sustained for different durations. The results are shown in
Fig. 5 B. A 1-min pulse of VIP gave rise to a peak level of
per1 induction ;20% of that obtained in response to a step
signal; for a 2-min pulse, the resulting peak level is;50% of
the step response and ;80% for a 5-min pulse; the 10-min
pulse response is almost indistinguishable from the step
response (Fig. 5 B). These results suggest that a short pulse
of VIP could be as effective as a step signal in inducing
per1 gene expression in our model, reﬂecting the high
sensitivity of the VPAC2 signaling pathway to short pulse
signals in vivo, as well as the robustness of the system to
pulse inputs of longer duration than 10 min. These results
have physiologically important consequences, as discussed
below.
Modeling VIP-induced phase shifts in the
circadian clock
Injection of VIP into SCN has been shown to induce phase
shifts in Syrian hamsters in vivo and in rat in vitro (3,4,8).
We linked our VPAC2 signaling model to the Leloup and
Goldbeter (24,25) circadian clock model to simulate the VIP-
induced phase shift. Based on the observation that Bmal1/
Clk- and CREB-mediated per1 promoter activation are at
least partially independent of each other (20), we postulated
two functional hypotheses about the mechanisms by which
the circadian clock and VPAC2 signaling jointly regulate
per1 induction (Materials and Methods, Eqs. 3 and 4). In
both cases, VIP induced phase shifts of the circadian clock.
The model represented by Eq. 3 generates phase shifts
similar to experimentally measured locomotor behavior
phase shifts induced by VIP injection into the SCN in vivo
(3), though with a larger phase delay than the experimental
observation (Fig. 6 A). In our simulation, VIP applied at late
FIGURE 6 Simulated VIP-induced phase shift in SCN circadian clock
using two different transcriptional regulation mechanisms. (A) Phase-
shifting as predicted with combined transcriptional saturation represented by
Eq. 3. (B) Phase-shifting as predicted with separate transcriptional saturation
represented by Eq. 4.
FIGURE 5 Model sensitivity analysis. (A) Model sensitivity to parametric
changes: parameters were varied individually in the range of 0.5, 0.95, 1.05,
and 2 times the original value; the 16 most sensitive parameters, which gave
rise to at least 30% changes in one of the four perturbations introduced, are
shown. (B) Model sensitivity to perturbation signal duration: short pulses of
VIP input were similarly effective as a step VIP input in inducing per1
transcription.
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night (rising phase of per1 mRNA near nadir) induced a 1 h
phase advance, which is nearly the same as in the experi-
mental data (60 vs. 50 min) (Fig. 6 A). However, VIP applied
at early night (lowering phase near per1 mRNA nadir)
induced an ;80 min phase delay, which was almost twice
the mean phase delay observed in experiments (40 min.)
(Fig. 6 B). The model represented by Eq. 4 generates phase
shifts similar in magnitude to what has been observed in
SCN neuron ﬁring rhythm in vitro (7,8) (Fig. 6 B). VIP
applied at late night induced a large 4 h phase advance
(compared to an average 3 h phase advance observed in the
SCN ﬁring rhythm) (Fig. 6 B). VIP applied at early night
induced a smaller 80 min phase delay, whereas VIP applied
to SCN slices induced a 60 min phase delay in SCN ﬁring
rhythms (8) (Fig. 6 B).
To study the phase dependence of the VIP-induced phase
shift, we simulated treatment with 100 nM VIP at each hour
of the entire circadian cycle and generated phase response
curves (Fig. 7 A). Lacking experimental VIP phase response
curve data, we compared the phase response curve to that of
another neuropeptide: gastrin-releasing peptide (GRP1–27)
(4). GRP1–27 is a ligand for a different G-protein-coupled
receptor that activates different signaling pathways (35,36).
Nevertheless, it has been demonstrated that GRP1–27 and
VIP induce similar phase shifts (4). Therefore, the GRP1–27
phase response curve is used currently as a reference for
comparison. The simulated phase response curve generated
using Eq. 3 closely resembles the phase response curves of
light and GRP1–27. The simulated phase response curve
generated using Eq. 4, however, shows VIP-induced phase
shifts throughout the circadian cycle, with phase advances
from late night to early day and phase delays from late day to
early night (Fig. 7 A).
We showed earlier that a short pulse of VIP induced
similar per1 transcriptional response as did the step signal
(Fig. 5 B). To see if a short pulse of VIP will also induce
appropriate phase shift throughout the circadian cycle, we
simulated VIP phase response curves using a 5 min, 100 nM
VIP pulse. The simulated phase response curve obtained
from the model in Eq. 3 was almost identical to that for the
step input in VIP (Fig. 7 B). The simulated phase response
curve obtained from the model in Eq. 4 still followed the
same general pattern as that resulting from the step input
signal; however, phase advances were smaller, whereas the
delay was about the same (Fig. 7 B). These results indicate
that short pulse VIP signals were effective not only in gen-
erating per1 response from the VIP signaling model but also
in phase-shifting the circadian clock model.
Transgenic mice overexpressing VPAC2 receptor showed
faster re-entrainment to photoperiod phase-shifting as com-
pared to wild-type animals (13). To investigate the modu-
lation of the phase response curve by VPAC2 receptor
overexpression or suppression, we simulated receptor over-
expression and suppression in our linked model, using as the
perturbation a step increase in the VIP signal (Fig. 8). With
the model in Eq. 3, lowering the receptor level to half of the
nominal level slightly reduced the peak phase shift for both
phase advance and phase delay. However, doubling the
receptor level showed a more pronounced phase advance
than phase delay (Fig. 8 A). For the model in Eq. 4, the entire
phase response curve was shifted either up or down in direct
relation to an increase or decrease in the receptor concen-
tration (Fig. 8 B). With reduced receptor concentration, the
phase delay became larger and phase advance smaller,
whereas with increased receptor concentrations, phase ad-
vance increased and phase delay decreased. For both models,
the changes in receptor level led to changes in phase-shifting
for whichever changes in phase advance were more pro-
nounced. These observations are in accordance with the
reported photoperiod phase-shifting (13), where animals
overexpressing the VPAC2 receptors showed a signiﬁcantly
enhanced re-entrainment to a phase advancing photoperiod
change. Based on the simulation, we would predict that a
single pulse of light or VIP will induce larger phase advances
FIGURE 7 Simulated VIP-induced phase response curve. (A) Phase
response curve induced by a step increase in VIP. Open circles are data from
GRP1–27-induced phase shift (see Piggins et al. (4)). (B) Phase response
curve induced by a 5-min short pulse. Solid line is the phase response curve
simulated with Eq. 3; dashed line is the phase response curve simulated with
Eq. 4.
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in the transgenic mice overexpressing VPAC2 as compared
to wild-type mice.
DISCUSSION
Circadian rhythms are generated by molecular oscillations
in cells that are modulated by extracellular stimuli. The SCN,
as the central oscillator, orchestrates coordinated rhythmic
processes throughout the body and receives many stimuli
originating from the environment and within the organism
itself. How the SCN integrates these numerous stimuli into a
consistent and precise molecular oscillation is not clear. In an
initial effort toward understanding this process, we report in
this work a mathematical model that describes VIP-activated
VPAC2 receptor signaling and a coupling of the model to the
circadian clock. We chose VIP for this in silico study because
it has been suggested to be a paracrine/autocrine molecule
contributing to the maintenance of sustained SCN oscilla-
tions, exerting its effect through the VPAC2 receptor (14,15).
Using a modeling framework for the cAMP/PKA signal-
ing pathway developed by Bhalla (26), we built a kinetic
model describing VIP-activated signaling in SCN cells that
culminates in circadian clock gene induction. We tuned our
model parameters to obtain good quantitative and qualitative
ﬁts to experimental data from the literature for VIP-induced
cAMP accumulation (Fig. 3), PKA activation (Fig. 4), CREB
phosphorylation (Fig. 4), and per1 gene induction (Fig. 4). It
is worth noting that the different measurements we used
to ﬁt the model were from different cells. We recognize that
different cells will potentially have different kinetics, and
that SCN cell speciﬁc measurements are needed for better
parameter estimates. Nonetheless, ﬁtting the model to ex-
perimental measurements gives us a working initial model
with which we can explore the VPAC2-mediated signaling
dynamics and functionality in a biologically relevant context
of the circadian clock. Importantly, linking the model to a
circadian clock showed good agreement with experimentally
observed phase shifts (Figs. 6 and 7).
Sensitivity analysis of the model allowed us to identify the
16 most sensitive model parameters for predicting per1 gene
induction (Fig. 5 A): vsp, vmp, kmp, k10, k12, k13, k14, k43, k46,
k49, k50, k51, k52, k55, k57, and k59. These were related to per1
mRNA synthesis, degradation, AC activation and deactiva-
tion, PKA inhibition, and CREB phosphorylation and
dephosphorylation. It is entirely reasonable that the model
prediction is sensitive to these parameters, given that they are
involved in the critical steps of cAMP production, PKA
activation, CREB activation, and mRNA synthesis. Surpris-
ingly, per1 transcriptional induction in our model did not
seem to be particularly sensitive to the rate of CREB
phosphorylation in the range tested, rather showing sensitiv-
ity to the rate of CREB dephosphorylation—indicating that
the rate of CREB dephosphorylation plays a more important
role in maintaining the activated CREB concentration.
Since the half-life of VIP in biological ﬂuid is only a few
minutes (34), VIP signal duration is a critical issue in tissues.
To test the sensitivity of the model to the VIP signal duration,
we simulated the response to short pulses of VIP inputs.
A 2-min VIP pulse was able to elicit a per1 induction up to
;50% of the peak level of the step VIP response, whereas a
5-min pulse response achieved ;80% of the step response
peak level (Fig. 5 B). The sensitivity of the model to the short
pulses, and the robustness of the response to variations in input
duration, once a critical duration is exceeded—observations
that have physiologically relevant consequences—seem to
validate the biological relevance of the model. The robust-
ness of the system response to pulse inputs with durations
.;10 min may provide a physiological advantage in that
variability in VIP release (that may arise from intrinsic
biological noise) does not lead to variability in the system
response: noisy input signals are converted into precise
output signals, provided that the input duration threshold
FIGURE 8 Phase advance is more sensitive than phase delay to recep-
tor level changes. (A) Simulated phase response curves using the model
represented by Eq. 3. (B) Simulated phase response using the model
represented by Eq. 4. Solid lines are simulated phase response curves with
nominal receptor levels. Dotted lines are simulated phase response curves
with doubled receptor levels. Dashed lines are simulated phase response
curves with half amount of nominal receptor levels.
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(;10 min) is exceeded. The fact that the system response
to VIP stimulation is intrinsically limited also may provide
a protective mechanism, preventing potentially cytotoxic
overstimulation. Intrinsically limited responses to a single
input also allow for the requirement of synergistic or com-
binatorial inputs to achieve sustained responses. Lastly, the
similarity between system responses to pulse and step inputs
indicates that experimental observations obtained using step
inputs may accurately reﬂect what occurs under physiolog-
ical conditions.
By linking our VPAC2 signaling model to the Leloup and
Goldbeter (24,25) mammalian circadian clock model, we
were able to simulate the phase-shifting effects of VIP on the
SCN clock as evidenced in the per1 gene oscillation. Using
two models for the combined circadian and VIP regulation
of per1 gene expression, we matched VIP-induced phase
shifts to experimentally observed phase shifts in locomotor
behavior rhythm and SCN neuronal ﬁring rhythm (Fig. 6).
In the ﬁrst case, the circadian clock regulated per1 gene
expression, mediated by Bmal1/Clk, and the VIP-induced
per1 gene expression, mediated by phosphorylated CREB,
are independent but they recruit the transcription machinery
in the same manner and thus can saturate per1 transcription
individually (Fig. 2 A). When Bmal1/Clk regulation of per1
transcription is saturated, phosphorylated CREB can no
longer induce transcription. Under such circumstances, a
step increase in the VIP signal phase-shifted the circadian
clock at early and late night as experimentally observed (4),
although the simulated phase delays early in the night were
greater than observed (Fig. 6 A). The simulated phase
response curve mimics the light phase response curve and
the GRP1–27 phase response curve (Fig. 7 A). Saturation of
per1 transcription by Bmal1/Clk during the day limited the
action of the VIP signaling. This effectively served as a
mechanism for circadian clock gating on VIP induction of
per1 gene expression and restricted phase shifts to the night
phase (Fig. 7 A). The limitation of the model is that it cannot
explain the large phase shift observed in vitro in SCN neuron
ﬁring rhythm (7).
In the second model, we described the circadian clock
regulation of per1 gene expression as completely indepen-
dent from VIP-induced per1 gene expression such that
Bmal1/Clk recruits the transcriptional machinery separately
from CREB. Thus CREB can induce per1 gene expression
even when the Bmal1/Clk induced transcription is at its
maximal rate (Fig. 2 B). The simulated phase shift matched
the observed in vitro SCN neuron ﬁring rhythm phase shift
(Fig. 6 B); and the phase response curve in this case showed
phase-shifting throughout the circadian cycle, thus necessi-
tating an additional gating mechanism to match the exper-
imentally observed phase response curve. However, this
model was able to describe the large phase shift induced by
VIP in SCN ﬁring rhythm observed in vitro (7,8). With
currently available data, it is not possible to determine
whether either model or some appropriate combination of the
two represents the mechanism of the integration of VIP
signaling and circadian clock function more realistically.
These different possibilities and their possible combined
contributions to the VIP-induced phase shift warrant further
experimental investigation.
It is interesting to note that with the limiting saturation rate
of transcription as described in Eq. 3, the limitation serves as
a gating mechanism for VIP-induced phase shift. Recently,
Geier and colleagues (37) modeled light entrainment of the
circadian oscillator based on the independence of light-
induced transcription of per1 gene from Bmal1/Clk-driven
transcription. In their model, a separate gating term was
introduced to ﬁt the light phase response curve. Our results
indicate that with a limiting maximum transcription rate,
clock-gated gene induction can be explained without an
additional gating term. In terms of gene regulation, this
makes sense: although various transcription factors can act
independently to activate transcription, they do act to recruit
transcriptional machinery to the same promoter; and the rate
of transcription is limited to how fast the transcriptional
machinery can be loaded onto the promoter and initiate
transcription (of course, with the assumption that there is no
interaction between the two sets of transcription factors).
Therefore, if two separate transcription factors bind to the
same promoter and they can function independently of each
other, their combined transcriptional activation is still limited
by the promoter capacity to initiate transcription.
We also tested if a short pulse of VIP is capable of phase-
shifting the circadian clock. Our simulation using a 5-min
pulse of VIP phase-shifted the circadian clock in a pattern
similar to the simulated response to a sustained VIP step
signal (Fig. 7 B)—an observation with physiological impli-
cations indicating that the model describes in vivo VIP
signaling pathways reasonably well in the sense that the
model response to short duration of VIP signals and the
induced phase response are similar to behavioral responses.
Varying the quantity of the VPAC2 receptor in the model
resulted in a corresponding variation in the magnitude of the
phase shift induced by VIP. Increasing the VPAC2 receptor
amount induced a larger phase advance using both coupling
mechanism represented by Eqs. 3 and 4 (Fig. 8), whereas
decreasing VPAC2 receptor amount reduced phase delay
with Eq. 3 but increased phase delays with Eq. 4 (Fig. 8).
However, changes in phase advances were more pronounced
than changes in phase delays. These observations agree with
the reported data from transgenic mice overexpressing
VPAC2 (13). Our simulation also predicts that a single pulse
of light or VIP will induce larger phase advances in the
transgenic mice overexpressing VPAC2 as compared to
wild-type mice. It would be interesting to see the prediction
veriﬁed experimentally using transgenic animals.
In summary, we have presented the development of a
kinetic model for the VIP-induced signal transduction
process in SCN cells and compared our model simulation
results to published data. These simulation results matched
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experimental data closely for cAMP accumulation, PKA
activation, CREB phosphorylation, and per1 gene induction.
When the model was linked to a circadian clock model,
the predicted VIP-induced phase shifts closely resembled
experimental observations for most of the circadian day.
Also, simulations of varying amounts of the VPAC2 receptor
predicted that overexpression of the receptor will cause a
larger phase advance. However, we recognize that in reality,
the VIP-induced phase shift is much more complicated than
what we have described so far. For example, it is evident that
the signaling pathways responsible for VIP signaling to the
clock include both protein kinase A and phospholipase C
pathways (6), and that mitogen-activated protein kinase
signaling also contributes to the phase-shifting effect of VIP
(7). Our next goal is to describe these signaling pathways and
incorporate them into our model. We will take an approach
of combined modeling and experimental validation to further
our understanding of the role of VIP in maintaining the SCN
circadian clock. Lastly, it is worth highlighting that other
computational models for the circadian clock mechanism are
available in the literature (38,39). It will be interesting to see
if differences in the phase shift can be generated from
simulations based on these other models.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
This study was supported by National Institutes of Health grant MH64459-
01, Defense Advanced Research Projects Agency research contract BAA-
01-26, and funding from Delaware Biotechnology Institute, University of
Delaware.
REFERENCES
1. Davidson, A. J., S. Yamazaki, and M. Menaker. 2003. SCN: ringmaster
of circadian circus or conductor of the circadian orchestra. Novartis
Found. Symp. 253:110–121.
2. Gillette, M. U., and J. W. Mitchell. 2002. Signaling in the supra-
chiasmatic nucleus: selectively responsive and integrative. Cell Tissue
Res. 309:99–107.
3. Albers, H. E., S. Y. Liou, E. G. Stopa, and R. T. Zoeller. 1991.
Interaction of colocalized neuropeptides: functional signiﬁcance in the
circadian timing system. J. Neurosci. 11:846–851.
4. Piggins, H. D., M. C. Antle, and B. Rusak. 1995. Neuropeptides phase
shift the mammalian circadian pacemaker. J. Neurosci. 15:5612–5622.
5. Cagampang, F. R., H. D. Higgins, W. J. Sheward, A. J. Harmar, and
C. W. Coen. 1998. Circadian changes in PACAP type 1 (PAC1) recep-
tor mRNA in the rat suprachiasmatic and supraoptic nuclei. Brain Res.
813:218–222.
6. Nielsen, H. S., J. Hannibal, and F. Fahrenkrug. 2002. Vasoactive
intestinal polypeptide induces per1 and per2 gene expression in the rat
suprachiasmatic nucleus late at night. Eur. J. Neurosci. 15:570–574.
7. Meyer-Spasche, A., and H. D. Piggins. 2004. Vasoactive intestinal
polypeptide phase-advances the rat suprachiasmatic nuclei circadian
pacemaker in vitro via protein kinase A and mitogen-activated protein
kinase. Neurosci. Lett. 358:91–94.
8. Reed, H. E., A. Meyer-Spasche, D. J. Cutler, C. W. Coen, and H. D.
Higgins. 2001. Vasoactive intestinal polypeptide (VIP) phase-shifts the
rat suprachiasmatic nucleus clock in vitro. Eur. J. Neurosci. 13:839–843.
9. Kalamatinos, T., I. Kallo, H. D. Piggins, and C. W. Coen. 2004.
Expression of VIP and/or PACAP receptor mRNA in peptide syn-
thesizing cells within the suprachiasmatic nucleus of the rat and its
efferent target sites. J. Comp. Neurol. 475:19–35.
10. Kallo, I., T. Kalamatianos, N. Wiltshire, S. Shen, W. J. Sheward, A. J.
Hamar, and C. W. Coen. 2004. Transgenic approach reveals expression
of the VPAC2 receptor in phenotypically deﬁned neurons in the mouse
suprachiasmatic nucleus and its efferent target sites. Eur. J. Neurosci.
19:2201–2211.
11. Usdin, T. B., T. I. Bonner, and E. Mezey. 1994. Two receptors for
vasoactive intestinal polypeptide with similar speciﬁcity and comple-
mentary distributions. Endocrinology. 135:2662–2680.
12. Laburthe, M., A. Corvineau, and J. C. Marie. 2002. VPAC receptors
for VIP and PACAP. Receptors Channels. 8:137–153.
13. Shen, S., C. Spratt, W. J. Sherward, I. Kallo, K. West, C. F. Morrison,
C. W. Coen, M. H. Marston, and A. J. Harmar. 2000. Overexpression
of the human VPAC2 receptor in the suprachiasmatic nucleus alters the
circadian phenotype of mice. Proc. Natl. Acad. Sci. USA. 97:11575–11580.
14. Harmar, A. J., H. M. Marston, S. Shen, C. Spratt, K. M. West, W. J.
Sheward, C. F. Morrison, J. R. Dorin, H. D. Piggins, J.-C. Reubi, J. S.
Kelly, E. S. Maywood, and M. H. Hastings. 2002. The VPAC2 receptor
is essential for circadian function in mouse suprachiasmatic nuclei.
Cell. 109:497–508.
15. Aton, S. J., C. S. Colwell, A. J. Harmar, J. Waschek, and E. D. Herzog.
2005. Vasoactive intestinal polypeptide mediates circadian rhythmicity
and synchrony in mammalian clock neurons. Nat. Neurosci. 8:476–483.
16. McCulloch, D. A., C. J. MacKenzie, M. S. Johnson, D. N. Robertson,
P. J. Holland, E. Ronaldson, E. M. Lutz, and R. Mitchell. 2002.
Additional signals from VPAC/PAC family receptors. Biochem. Soc.
Trans. 30:441–446.
17. Mangeat, P., J. Marvaldi, O. A. Ahmed, and G. Marchis-Mouren.
1981. Parallel activation of cyclic AMP phosphodiesterase and cyclic
AMP-dependent protein kinase in two human gut adenocarcinoma cells
(HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP)
and other effectors activating the cyclic AMP system. Regul. Pept.
1:397–414.
18. Schomerus, C., E. Maronde, E. Laedtke, and H. W. Korf. 1996.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-
activating polypeptide (PACAP) induce phosphorylation of the
transcription factor CREB in subpopulations of rat pinealocytes:
immunocytochemical and immunochemical evidence. Cell Tissue Res.
286:305–313.
19. Lin, J. H., Y. C. Jang, D. C. Wen, and F. F. Wang. 1996. Synergistic
activation of cAMP and calcium on cAMP-response-element-mediated
gene expression in GH3 pituitary tumor cells. Cell. Signal. 8:111–115.
20. Travnickova-Bendova, Z., N. Cermakian, S. M. Reppert, and P.
Sassone-Corsi. 2002. Bimodal regulation of mPeriod promoters by
CREB-dependent signaling and CLOCK/BMAL1 activity. Proc. Natl.
Acad. Sci. USA. 99:7728–7733.
21. Rea, M. A. 1990. VIP-stimulated cyclic AMP accumulation in supra-
chiasmatic hypothalamus. Brain Res. Bull. 25:843–847.
22. Vanecek, J., and K. Watanabe. 1998. Melatonin inhibits the increase of
cyclic AMP in rat suprachiasmatic neurons induced by vasoactive
intestinal peptide. Neurosci. Lett. 252:21–24.
23. Shinohara, K., T. Funabashi, and F. Kimura. 1999. Temporal proﬁles
of vasoactive intestinal polypeptide precursor mRNA and its receptor
mRNA in the rat suprachiasmatic nucleus. Brain Res. Mol. Brain Res.
63:262–267.
24. Leloup, J. C., and A. Goldbeter. 2003. Toward a detailed computa-
tional model for the mammalian circadian clock. Proc. Natl. Acad. Sci.
USA. 100:7051–7056.
25. Leloup, J. C., and A. Goldbeter. 2004. Modeling the mammalian
circadian clock: Sensitivity analysis and multiplicity of oscillatory
mechanisms. J. Theor. Biol. 230:541–562.
1570 Hao et al.
Biophysical Journal 90(5) 1560–1571
26. Bhalla, U. S. 2002. Use of Kinetikit and GENESIS for modeling
signaling pathways. Methods Enzymol. 345:3–23.
27. Langlet, C., N. Gaspard, I. Nachtergael, P. Robberecht, and I. Langer.
2004. Comparative efﬁcacy of VIP and analogs on activation and inter-
nalization of the recombinant VPAC2 receptor expressed in CHO cells.
Peptides. 25:2079–2086.
28. Mackenzie, C. J., E. M. Lutz, M. S. Johnson, D. N. Robertson, P. J.
Holland, and R. Mitchell. 2001. Mechanisms of phospholipase C acti-
vation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase
activating polypeptide type 2 receptor. Endocrinology. 142:1209–1217.
29. Saltelli, A., M. Ratto, S. Taratolla, and F. Campolongo. 2005. Sen-
sitivity analysis for chemical models. Chem. Rev. 105:2811–2827.
30. Ueda, H. R., M. Hagiwara, and H. Kitano. 2001. Robust oscillations
within the interlocked feedback model of Drosophila circadian rhythm.
J. Theor. Biol. 210:401–406.
31. Shampine, L. F., and M. W. Reichelt. 1997. The MATLAB ODE suite.
SIAM J. Sci. Comput. 18:1–22.
32. Yagita, K., and H. Okamura. 2000. Forskolin induces circadian gene
expression of rPer1, Per2, and DBP in mammalian rat-1 ﬁbroblasts.
FEBS Lett. 465:79–82.
33. Rosbash, M. 1998. Why the rat-1 ﬁbroblast should replace the SCN as
the in vitro model of choice. Cell. 93:917–919.
34. Sethi, V., H. Onyuksel, and I. Rubinstein. 2005. Liposomal vasoactive
intestinal peptide. Methods Enzymol. 391:377–395.
35. Fitzgerald, L. R., I. J. Mannan, G. M. Dytko, H. L. Wu, and P. Nambi.
1999. Measurement of responses from Gi- Gs- or Gq-coupled receptors
by a multiple response element/cAMP response element-directed reporter
assay. Anal. Biochem. 275:54–61.
36. Garcia, L. J., T. K. Pradhan, H. C. Weber, T. W. Moody, and R. T.
Jensen. 1997. The gastrin-releasing peptide receptor is differentially
coupled to adenylate cyclase and phospholipase C in different tissues.
Biochim. Biophys. Acta. 1356:343–354.
37. Geier, F., S. Becker-Weimann, A. Kramer, and H. Herzel. 2005.
Entrainment in a model of the mammalian circadian oscillator. J. Biol.
Rhythms. 20:83–93.
38. Forgers, D. B., and C. S. Peskin. 2003. A detailed predictive model of
the mammalian circadian clock. Proc. Natl. Acad. Sci. USA. 100:
14806–14811.
39. Kurosawa, G., and Y. Iwasa. 2002. Saturation of enzyme kinetics in
circadian clock models. J. Biol. Rhythms. 17:568–577.
Modeling VPAC2 Signaling in the SCN 1571
Biophysical Journal 90(5) 1560–1571
